Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy

BackgroundDiabetes mellitus is a risk factor for coronary artery disease and diabetic cardiomyopathy, and adversely impacts outcomes following coronary artery bypass grafting. Current treatments focus on macro-revascularization and neglect the microvascular disease typical of diabetes mellitus-induced cardiomyopathy (DMCM). We hypothesized that engineered smooth muscle cell (SMC)-endothelial progenitor cell (EPC) bi-level cell sheets could improve ventricular dysfunction in DMCM.MethodsPrimary mesenchymal stem cells (MSCs) and EPCs were isolated from the bone marrow of Wistar rats, and MSCs were differentiated into SMCs by culturing on a fibronectin-coated dish. SMCs topped with EPCs were detached from a temperature-responsive culture dish to create an SMC-EPC bi-level cell sheet. A DMCM model was induced by intraperitoneal streptozotocin injection. Four weeks after induction, rats were randomized into 3 groups: control (no DMCM induction), untreated DMCM, and treated DMCM (cell sheet transplant covering the anterior surface of the left ventricle).ResultsSMC-EPC cell sheet therapy preserved cardiac function and halted adverse ventricular remodeling, as demonstrated by echocardiography and cardiac magnetic resonance imaging at 8 weeks after DMCM induction. Myocardial contrast echocardiography demonstrated that myocardial perfusion and microvascular function were preserved in the treatment group compared with untreated animals. Histological analysis demonstrated decreased interstitial fibrosis and increased microvascular density in the SMC-EPC cell sheet-treated group.ConclusionsTreatment of DMCM with tissue-engineered SMC-EPC bi-level cell sheets prevented cardiac dysfunction and microvascular disease associated with DMCM. This multi-lineage cellular therapy is a novel, translatable approach to improve microvascular disease and prevent heart failure in diabetic patients.

[1]  Masashi Kawamura,et al.  Layered smooth muscle cell–endothelial progenitor cell sheets derived from the bone marrow augment postinfarction ventricular function , 2017, The Journal of thoracic and cardiovascular surgery.

[2]  S. McDonald,et al.  Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. , 2011, Clinical science.

[3]  M. di Mauro,et al.  Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  Pascal Meier,et al.  The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. , 2005, Journal of the American College of Cardiology.

[5]  Qun Liu,et al.  Transplanted bone marrow mesenchymal stem cells protects myocardium by regulating 14-3-3 protein in a rat model of diabetic cardiomyopathy. , 2014, International journal of clinical and experimental pathology.

[6]  B. Eliasson,et al.  Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting. , 2015, Journal of the American College of Cardiology.

[7]  Y. Yoon,et al.  Progressive Attenuation of Myocardial Vascular Endothelial Growth Factor Expression Is a Seminal Event in Diabetic Cardiomyopathy: Restoration of Microvascular Homeostasis and Recovery of Cardiac Function in Diabetic Cardiomyopathy After Replenishment of Local Vascular Endothelial Growth Factor , 2005, Circulation.

[8]  P. Atluri,et al.  Normalization of Postinfarct Biomechanics Using a Novel Tissue-Engineered Angiogenic Construct , 2013, Circulation.

[9]  D. Schwenke,et al.  Dynamic Synchrotron Imaging of Diabetic Rat Coronary Microcirculation In Vivo , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[10]  C. Betsholtz,et al.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.

[11]  F. Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[12]  Yuan-sheng Gao,et al.  Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension. , 2016, American journal of respiratory cell and molecular biology.

[13]  P. Nguyen,et al.  Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review. , 2016, JAMA cardiology.

[14]  M. Kohno,et al.  Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. , 2002, Cardiovascular research.

[15]  Xiao-dong Zhou,et al.  Real-time myocardial contrast echocardiography in rat: infusion versus bolus administration. , 2009, Ultrasound in medicine & biology.

[16]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[17]  J. R. Fitzpatrick,et al.  Stromal Cell-Derived Factor-1&agr; Activation of Tissue-Engineered Endothelial Progenitor Cell Matrix Enhances Ventricular Function After Myocardial Infarction by Inducing Neovasculogenesis , 2010, Circulation.

[18]  Cheng-Chung Cheng,et al.  Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses , 2012, BMC Genomics.

[19]  P. Bertrand,et al.  Myoendothelial Contacts, Gap Junctions, and Microdomains: Anatomical Links to Function? , 2012, Microcirculation.

[20]  J. Rouleau,et al.  Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial , 2014, European journal of heart failure.

[21]  G. Schaer,et al.  Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials , 2016, Cell transplantation.

[22]  Joshua M Hare,et al.  Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. , 2016, Physiological reviews.

[23]  M. Boulton,et al.  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock , 2009, The Journal of experimental medicine.

[24]  P. Berger,et al.  Functional relevance of genetic variations of endothelial nitric oxide synthase and vascular endothelial growth factor in diabetic coronary microvessel dysfunction , 2013, Clinical and experimental pharmacology & physiology.

[25]  A. Roguin,et al.  Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus , 2009, Cardiovascular diabetology.

[26]  Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy , 2015, Molecular and Cellular Biochemistry.

[27]  Y. Woo,et al.  Isolation and trans-differentiation of mesenchymal stromal cells into smooth muscle cells: Utility and applicability for cell-sheet engineering. , 2016, Cytotherapy.

[28]  Haobo Li,et al.  Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy , 2016, Cardiovascular Diabetology.

[29]  M. Brownlee,et al.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes. , 2016, Circulation research.

[30]  Biao Xu,et al.  Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. , 2009, Biochemical and biophysical research communications.

[31]  Wei Sun,et al.  Mechanisms Contributing to the Progression of Ischemic and Nonischemic Dilated Cardiomyopathy: Possible Modulating Effects of Paracrine Activities of Stem Cells. , 2015, Journal of the American College of Cardiology.

[32]  B. Lévy,et al.  Coadministration of Endothelial and Smooth Muscle Progenitor Cells Enhances the Efficiency of Proangiogenic Cell-Based Therapy , 2008, Circulation research.

[33]  Y. Woo,et al.  Spatially Oriented, Temporally Sequential Smooth Muscle Cell-Endothelial Progenitor Cell Bi-Level Cell Sheet Neovascularizes Ischemic Myocardium , 2013, Circulation.

[34]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[35]  G. Spinetti,et al.  Diabetes Mellitus Induces Bone Marrow Microangiopathy , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[36]  A. Fenning,et al.  Echocardiographic assessment of cardiac structure and function in rats. , 2002, Heart, lung & circulation.

[37]  P. Menasché,et al.  Stem cells for the treatment of heart failure. , 2016, Current research in translational medicine.

[38]  H. Ichikawa,et al.  Allogenic mesenchymal stem cell transplantation has a therapeutic effect in acute myocardial infarction in rats. , 2008, Journal of molecular and cellular cardiology.

[39]  M. Woodward,et al.  Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. , 2015, The lancet. Diabetes & endocrinology.

[40]  Jianbo Yu,et al.  Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats. , 2012, International journal of molecular medicine.

[41]  U. Nguyen,et al.  The Simple Western[trade]: a gel-free, blot-free, hands-free Western blotting reinvention , 2011 .

[42]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[43]  D. Schwenke,et al.  Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation , 2013, Cardiovascular Diabetology.

[44]  Jun Jiang,et al.  Stem cells and diabetic cardiomyopathy: from pathology to therapy , 2016, Heart Failure Reviews.

[45]  N. Frangogiannis,et al.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. , 2016, Journal of molecular and cellular cardiology.

[46]  E. Halpern,et al.  In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3–Deficient Mice , 2007, Circulation.

[47]  J. Grapsa,et al.  Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? , 2016, European journal of clinical investigation.

[48]  L. Lerman,et al.  Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension , 2015, Cell transplantation.

[49]  E. Blackstone,et al.  Coronary artery bypass grafting in diabetics: A growing health care cost crisis. , 2015, The Journal of thoracic and cardiovascular surgery.